MYO5B and bile salt export pump contribute to cholestatic liver disorder in microvillous inclusion disease

Muriel Girard1, Florence Lacaille, Virginie Verkarre

  • 1Department of Pediatric Gastroenterology and Hepatology, Necker Enfants-Malades Hospital, Assistance Publique-Hôpitaux de Paris, Université Paris Descartes-Sorbonne Cité, Paris, France; INSERM, UMR 781, Université Paris Descartes-Sorbonne Cité, Institut Imagine, Paris, France.

Hepatology (Baltimore, Md.)
|December 31, 2013
PubMed
Abstract

Insights

Microvillous inclusion disease (MVID), caused by MYO5B gene mutations, can lead to a progressive liver disease resembling PFIC. Impaired MYO5B function disrupts bile flow and increases bile acid absorption, impacting MVID patient outcomes.

Area of Science:

  • Hepatology
  • Gastroenterology
  • Genetics

Background:

  • Microvillous inclusion disease (MVID) is a congenital enterocyte disorder linked to MYO5B gene mutations.
  • MVID often causes intractable diarrhea, frequently requiring intestinal transplantation (ITx).
  • A subset of MVID patients develop a progressive cholestatic liver disease, similar to progressive familial intrahepatic cholestasis (PFIC).

Purpose of the Study:

  • To investigate the mechanisms by which MYO5B mutations contribute to hepatic biliary dysfunction and cholestasis in MVID patients.
  • To analyze clinical features, outcomes, and liver histology in MVID patients with cholestasis.
  • To identify potential therapeutic strategies for MVID-associated cholestasis.

Main Methods:

  • Review of clinical and biological data from 28 MVID patients, focusing on 8 with liver disease.
  • Analysis of pretransplant liver biopsies using immunostaining and electron microscopy.
  • Genetic analysis to rule out mutations in known cholestasis genes (ABCB11/BSEP, ATP8B1/FIC1).

Main Results:

  • Cholestasis occurred before or after ITx, characterized by jaundice, pruritus, and elevated bile acids with normal GGT.
  • Liver histology revealed canalicular cholestasis, fibrosis, and ultrastructural bile canaliculi abnormalities.
  • Immunohistochemistry showed abnormal distribution of MYO5B, RAB11A, and BSEP in hepatocytes, suggesting impaired apical recycling and BSEP targeting.
  • Interruption of enterohepatic bile acid cycling provided the most effective long-term remission.

Conclusions:

  • MVID patients are susceptible to a PFIC-like liver disease that can negatively impact outcomes post-ITx.
  • Cholestasis in MVID arises from impaired MYO5B/RAB11A apical recycling, defective BSEP targeting, and increased ileal bile acid absorption.
  • Combined liver-intestinal transplantation should be considered for MVID patients with severe cholestasis, as it can worsen after ITx.

Related Concept Videos

Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
900
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.1K
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.5K
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
29
Intralumenal Vesicles and Multivesicular Bodies01:38

Intralumenal Vesicles and Multivesicular Bodies

Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
4.0K
Bile01:19

Bile

Bile is a crucial bodily fluid, characterized by its yellow-green color and alkaline nature. Produced in the liver, it is transported through the common hepatic duct into either the cystic duct, leading to the gallbladder, or directly into the common bile duct. The flow of bile is regulated by the sphincter of Oddi located at the entrance of the duodenum. When this sphincter is closed, bile is redirected to the gallbladder for storage and concentration.
Bile is released when dietary fats enter...
6.2K